AbCellera Biologics's total assets for Q2 2025 were $1.40B, an increase of 4.30% from the previous quarter. ABCL total liabilities were $394.99M for the fiscal quarter, a 22.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.